At a glance
ClinicalIndex Comparison RecordN/ACompleted· 18 enrolled
Drug / intervention
Jewel Patch Wearable Cardioverter Defibrillator (P-WCD)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Jewel Electrophysiology (EP) Lab Study
In Brief
A clinical study evaluating Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) for Sudden Cardiac Arrest. Completed, enrolled 18 participants across 1 site.
Detailed Summary
Single arm open label evaluation of the Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) defibrillation waveform in adult cardiac patients.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSudden Cardiac Arrest
CountriesCzechia
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
Enrollment StartNov 2018
Primary CompletionOct 2021
First PostedAug 2022
Study CompletionApr 2024
TodayJul 2026
First PostedAug 5, 2022
Enrollment StartNov 27, 2018
Primary CompletionOct 7, 2021
Study CompletionApr 17, 2024
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 3.9 years ago
Interventions
Jewel Patch Wearable Cardioverter Defibrillator (P-WCD)device
Automatic external cardioverter defibrillator that monitors patients at risk for SCA and provides a therapeutic shock if needed.